Ipsen Shares Fall After Forecast of Lower Margin
By Adria Calatayud Ipsen shares fell after the French pharmaceutical company forecast lower profitability this year as it expects extra...
Source: marketwatch.com
Fr Ipn News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Fr Ipn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Fr Ipn Today - Breaking & Trending Today
Ipsen Reports Positive Results in Late-Stage Trial of Cancer Drug Cabometyx
By Helena Smolak Ipsen's phase-three trial of prostate cancer drug Cabometyx yielded positive results, the company said late Monday. The French...
Source: marketwatch.com
Ipsen, Genfit Drug Fights Liver Disease Progression, Phase-Three Trial Finds
By David Sachs A drug to treat chronic liver disease developed by Ipsen and Genfit has gained a positive result in its phase-three trial, the companies said....
Source: marketwatch.com
Exelixis, Ipsen Say Prostate Cancer Phase 3 Trial Met One of Two Main Goals
By Adria Calatayud Exelixis and Ipsen said a phase 3 clinical trial evaluating a combination of drugs cabozantinib and atezolizumab in metastatic...
Source: marketwatch.com
Ipsen Shares Rise After It Upgrades 2023 Outlook
By David Sachs Ipsen shares rose Thursday after the French pharmaceutical firm raised its 2023 outlook. At 0749 GMT, Ipsen shares were up 4% to EUR114.50....
Source: marketwatch.com